• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

视网膜变性 rd6 鼠模型中的基因治疗。

Gene therapy in the rd6 mouse model of retinal degeneration.

机构信息

Department of Ophthalmology, College of Medicine, University of Florida, 1600 SW Archer Road, 32610, Gainesville, FL, USA,

出版信息

Adv Exp Med Biol. 2014;801:711-8. doi: 10.1007/978-1-4614-3209-8_89.

DOI:10.1007/978-1-4614-3209-8_89
PMID:24664762
Abstract

The rd6 mouse is a natural model of an RPE-based (retinal pigment epithelium) autosomal recessive retinitis pigmentosa (RP) caused by mutations in the Mfrp (membrane-type frizzled related protein) gene. Previously, we showed that subretinal delivery of the wild-type mouse Mfrp mediated by a tyrosine-capsid mutant scAAV8 (Y733F) vector prevented photoreceptor cell death, and rescued retinal function as assessed by electroretinography. In this study, we describe the effect of gene therapy on the retinal structure and function in rd6 mice using a quadruple (Y272, 444, 500, 730F) tyrosine-capsid mutant scAAV2 viral vector delivered subretinally at postnatal day 14 (P14). We show that therapy is effective at slowing the photoreceptor degeneration, and in preventing the characteristic accumulation of abnormal phagocytic cells in the subretinal space. MFRP expression as driven by the ubiquitous chicken β-actin (smCBA) promoter in treated rd6 mice was found predominantly in the RPE apical membrane and the entire length of its microvilli, as well as in the photoreceptor inner segments, suggesting a potential interaction with actin filaments. In spite of preserving retinal morphology, the effects of gene therapy on retinal function were minimal, suggesting that the scAAV8 (Y733F) vector may be more efficient for the treatment of RP caused by Mfrp mutations.

摘要

rd6 小鼠是一种由 Mfrp(膜型卷曲相关蛋白)基因突变引起的 RPE 型(视网膜色素上皮)常染色体隐性视网膜色素变性(RP)的天然模型。此前,我们发现通过酪氨酸衣壳突变 scAAV8(Y733F)载体进行的野生型小鼠 Mfrp 的视网膜下递送可防止光感受器细胞死亡,并通过视网膜电图评估来挽救视网膜功能。在这项研究中,我们使用在出生后第 14 天(P14)进行视网膜下递送的四重(Y272、444、500、730F)酪氨酸衣壳突变 scAAV2 病毒载体描述了基因治疗对 rd6 小鼠视网膜结构和功能的影响。我们表明,该疗法可有效减缓光感受器变性,并防止异常吞噬细胞在视网膜下空间的特征性积累。在治疗后的 rd6 小鼠中,由普遍存在的鸡β-肌动蛋白(smCBA)启动子驱动的 MFRP 表达主要在 RPE 顶膜及其微绒毛的全长以及光感受器内节中发现,表明与肌动蛋白丝可能存在潜在相互作用。尽管保留了视网膜形态,但基因治疗对视网膜功能的影响很小,这表明 scAAV8(Y733F)载体可能更适合治疗由 Mfrp 突变引起的 RP。

相似文献

1
Gene therapy in the rd6 mouse model of retinal degeneration.视网膜变性 rd6 鼠模型中的基因治疗。
Adv Exp Med Biol. 2014;801:711-8. doi: 10.1007/978-1-4614-3209-8_89.
2
Gene therapy for retinitis pigmentosa caused by MFRP mutations: human phenotype and preliminary proof of concept.MFRP 基因突变致视网膜色素变性的基因治疗:人体表型及初步概念验证。
Hum Gene Ther. 2012 Apr;23(4):367-76. doi: 10.1089/hum.2011.169. Epub 2012 Jan 26.
3
Gene therapy in patient-specific stem cell lines and a preclinical model of retinitis pigmentosa with membrane frizzled-related protein defects.针对患者特异性干细胞系的基因治疗以及患有膜卷曲相关蛋白缺陷的视网膜色素变性临床前模型。
Mol Ther. 2014 Sep;22(9):1688-97. doi: 10.1038/mt.2014.100. Epub 2014 Jun 4.
4
Gene Therapy Restores Mfrp and Corrects Axial Eye Length.基因治疗恢复 Mfrp 并纠正眼球轴向长度。
Sci Rep. 2017 Nov 23;7(1):16151. doi: 10.1038/s41598-017-16275-8.
5
Long-term retinal function and structure rescue using capsid mutant AAV8 vector in the rd10 mouse, a model of recessive retinitis pigmentosa.利用衣壳突变型 AAV8 载体对 rd10 小鼠(一种隐性视网膜色素变性模型)进行长期视网膜功能和结构挽救。
Mol Ther. 2011 Feb;19(2):234-42. doi: 10.1038/mt.2010.273. Epub 2010 Dec 7.
6
Mid-stage intervention achieves similar efficacy as conventional early-stage treatment using gene therapy in a pre-clinical model of retinitis pigmentosa.在视网膜色素变性的临床前模型中,中期干预使用基因疗法与传统早期治疗达到相似的疗效。
Hum Mol Genet. 2014 Jan 15;23(2):514-23. doi: 10.1093/hmg/ddt452. Epub 2013 Sep 18.
7
174delG mutation in mouse MFRP causes photoreceptor degeneration and RPE atrophy.174delG 突变导致小鼠 MFRP 感光细胞变性和 RPE 萎缩。
Invest Ophthalmol Vis Sci. 2011 Sep 14;52(10):7256-66. doi: 10.1167/iovs.11-8112.
8
Gene therapy restores vision and delays degeneration in the CNGB1(-/-) mouse model of retinitis pigmentosa.基因治疗恢复了视功能并延缓了色素性视网膜炎 CNGB1(-/-) 小鼠模型的变性。
Adv Exp Med Biol. 2014;801:733-9. doi: 10.1007/978-1-4614-3209-8_92.
9
Membrane frizzled-related protein is necessary for the normal development and maintenance of photoreceptor outer segments.膜卷曲相关蛋白对于光感受器外段的正常发育和维持是必需的。
Vis Neurosci. 2008 Jul-Aug;25(4):563-74. doi: 10.1017/S0952523808080723.
10
AAV8(Y733F)-mediated gene therapy in a Spata7 knockout mouse model of Leber congenital amaurosis and retinitis pigmentosa.在莱伯先天性黑蒙和视网膜色素变性的Spata7基因敲除小鼠模型中,通过腺相关病毒8型(Y733F)介导的基因治疗
Gene Ther. 2015 Aug;22(8):619-27. doi: 10.1038/gt.2015.42. Epub 2015 May 12.

引用本文的文献

1
Improved gene therapy for MFRP deficiency-mediated retinal degeneration by knocking down endogenous bicistronic and transcript.通过敲低内源性双顺反子转录本改善MFRP缺乏介导的视网膜变性的基因治疗
Mol Ther Nucleic Acids. 2023 May 9;32:843-856. doi: 10.1016/j.omtn.2023.05.001. eCollection 2023 Jun 13.
2
Distinct Phenotypic Consequences of Pathogenic Mutants Associated with Late-Onset Retinal Degeneration.与晚发性视网膜变性相关的致病性突变导致的不同表型后果。
Am J Pathol. 2023 Nov;193(11):1706-1720. doi: 10.1016/j.ajpath.2022.10.004. Epub 2022 Oct 31.
3
Update of application of olfactory ensheathing cells and stem cells/exosomes in the treatment of retinal disorders.
嗅鞘细胞和干细胞/外泌体在治疗视网膜疾病中的应用更新。
Stem Cell Res Ther. 2022 Jan 10;13(1):11. doi: 10.1186/s13287-021-02685-z.
4
Membrane-type frizzled-related protein regulates lipidome and transcription for photoreceptor function.膜型卷曲相关蛋白调节脂质组和转录以维持光感受器功能。
FASEB J. 2020 Jan;34(1):912-929. doi: 10.1096/fj.201902359R. Epub 2019 Nov 28.
5
Long-Term Effects of Gene Therapy in a Novel Mouse Model of Human -Associated Retinopathy.新型人类相关性视网膜病变小鼠模型中的基因治疗的长期效果。
Hum Gene Ther. 2019 May;30(5):632-650. doi: 10.1089/hum.2018.192. Epub 2019 Jan 16.
6
CLINICAL PROGRESS IN INHERITED RETINAL DEGENERATIONS: GENE THERAPY CLINICAL TRIALS AND ADVANCES IN GENETIC SEQUENCING.遗传性视网膜变性的临床进展:基因治疗临床试验与基因测序进展
Retina. 2017 Mar;37(3):417-423. doi: 10.1097/IAE.0000000000001341.
7
Use of human pluripotent stem cells to study and treat retinopathies.利用人类多能干细胞研究和治疗视网膜病变。
World J Stem Cells. 2015 Apr 26;7(3):596-604. doi: 10.4252/wjsc.v7.i3.596.
8
Recent advances of stem cell therapy for retinitis pigmentosa.视网膜色素变性干细胞治疗的最新进展
Int J Mol Sci. 2014 Aug 20;15(8):14456-74. doi: 10.3390/ijms150814456.